Triple Therapy: Proven Results for Patients Living with HIV
The DHHS Guidelines recommend the use of a complete triple therapy based on a dual NRTI plus an INSTI for treatment initiation.1
Today's regimens offer sustained virologic efficacy, better tolerability and toxicity profiles, and relative ease of use.1
Download the complete infographic, HIV Treatment Then and Now: Strides in HIV Therapy, to see how best practices have changed along with development of new drug regimens.
PATIENT CONSIDERATIONS WHEN SELECTING A THERAPY
Potential side effects and regimen convenience are important factors when selecting a regimen.1 Consider a simplified regimen to help patients achieve their treatment goals.
According to the DHHS Guidelines, a regimen that includes all 3 components that is taken one time a day is easier for patients to use.1 Additionally, individualized care involves specific treatment considerations for a number of special patient populations and clinical scenarios. These include1:
- Results of pretreatment genotypic drug-resistance testing
- From acute infection to established
- High viral load and low CD4 count
- Initiating treatment or switching therapy
- Various health needs: pregnancy, coinfection, comorbidities, and interactions with concomitant medications
Consider a complete triple therapy for patients living with HIV